U.S. Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices), By Therapy Area (Stroke, Parkinson’s Disease), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Product
                        1.1.2. Therapy area
                        1.1.3. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                        1.4.1. Data analysis models
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                        1.6.1. Commodity flow analysis (Model 1)
                            1.6.1.1. Approach 1: Commodity flow approach
                        1.6.2. Volume price analysis (Model 2)
                            1.6.2.1. Approach 2: Volume price analysis
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. Therapy area outlook
                    2.3. Competitive Insights
Chapter 3. Neurorehabilitation Devices Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Industry Value Chain Analysis
                        3.3.1. Reimbursement framework
                    3.4. Market Dynamics
                        3.4.1. Market driver analysis
                            3.4.1.1. Increasing incidence of neurological diseases
                            3.4.1.2. Technological advancements
                            3.4.1.3. Increasing clinical studies for the neurorehabilitation devices product development
                        3.4.2. Market restraint analysis
                            3.4.2.1. High cost of devices
                            3.4.2.2. Complex regulatory framework
                    3.5. U.S. Neurorehabilitation Devices Market Analysis Tools
                        3.5.1. Industry Analysis - Porter’s Five Forces
                            3.5.1.1. Supplier power
                            3.5.1.2. Buyer power
                            3.5.1.3. Substitution threat
                            3.5.1.4. Threat of new entrant
                            3.5.1.5. Competitive rivalry
                        3.5.2. PESTEL Analysis
                            3.5.2.1. Political landscape
                            3.5.2.2. Technological landscape
                            3.5.2.3. Economic landscape
                        3.5.3. Major Deals & Strategic Alliances Analysis
                        3.5.4. Market Entry Strategies
Chapter 4. U.S. Neurorehabilitation Devices Market: Product Estimates & Trend Analysis
                    4.1. Definitions and Scope
                        4.1.1. Neurorobotics
                        4.1.2. Brain-Computer Interface
                        4.1.3. Wearable Devices
                        4.1.4. Non-Invasive Stimulators
                    4.2. Product Market Share, 2023 & 2030
                    4.3. Segment Dashboard
                    4.4. U.S. Neurorehabilitation Devices Market by Product Outlook
                    4.5. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.5.1. Neurorobotics
                            4.5.1.1. Neurorobotics market estimates and forecast 2018 to 2030 (USD Million)
                        4.5.2. Brain-Computer Interface
                            4.5.2.1. Brain-computer interface market estimates and forecast 2018 to 2030 (USD Million)
                        4.5.3. Wearable Devices
                            4.5.3.1. Wearable devices market estimates and forecast 2018 to 2030 (USD Million)
                        4.5.4. Non-Invasive Stimulators
                            4.5.4.1. Non-invasive stimulators market estimates and forecast 2018 to 2030 (USD Million)
                        4.5.5. Others
                            4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. U.S. Neurorehabilitation Devices Market: Therapy area Estimates & Trend Analysis
                    5.1. Definitions and Scope
                        5.1.1. Stroke
                        5.1.2. Parkinson’s Disease
                        5.1.3. Multiple Sclerosis
                        5.1.4. Cerebral Palsy
                        5.1.5. Others
                    5.2. Therapy area Market Share, 2023 & 2030
                    5.3. Segment Dashboard
                    5.4. U.S. Neurorehabilitation Devices Market by Therapy area Outlook
                    5.5. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.5.1. Stroke
                            5.5.1.1. Stroke market estimates and forecast 2018 to 2030 (USD Million)
                        5.5.2. Parkinson’s Disease
                            5.5.2.1. Parkinson’s disease market estimates and forecast 2018 to 2030 (USD Million)
                        5.5.3. Multiple Sclerosis
                            5.5.3.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million)
                        5.5.4. Cerebral Palsy
                            5.5.4.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million)
                        5.5.5. Others
                            5.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company/Competition Categorization
                        6.2.1. Innovators
                    6.3. Vendor Landscape
                        6.3.1. List of key distributors and channel partners
                        6.3.2. Key customers
                        6.3.3. Key company market share analysis, 2023
                        6.3.4. Bioventus
                            6.3.4.1. Company overview
                            6.3.4.2. Financial performance
                            6.3.4.3. Product benchmarking
                            6.3.4.4. Strategic initiatives
                        6.3.5. Ectron
                            6.3.5.1. Company overview
                            6.3.5.2. Financial performance
                            6.3.5.3. Product benchmarking
                            6.3.5.4. Strategic initiatives
                        6.3.6. Hocoma
                            6.3.6.1. Company overview
                            6.3.6.2. Financial performance
                            6.3.6.3. Product benchmarking
                            6.3.6.4. Strategic initiatives
                        6.3.7. Medtronic
                            6.3.7.1. Company overview
                            6.3.7.2. Financial performance
                            6.3.7.3. Product benchmarking
                            6.3.7.4. Strategic initiatives
                        6.3.8. Tyromotion Inc.
                            6.3.8.1. Company overview
                            6.3.8.2. Financial performance
                            6.3.8.3. Product benchmarking
                            6.3.8.4. Strategic initiatives
                        6.3.9. Abbott
                            6.3.9.1. Company overview
                            6.3.9.2. Financial performance
                            6.3.9.3. Product benchmarking
                            6.3.9.4. Strategic initiatives
                        6.3.10. Biometrics Ltd
                            6.3.10.1. Company overview
                            6.3.10.2. Financial performance
                            6.3.10.3. Product benchmarking
                            6.3.10.4. Strategic initiatives
                        6.3.11. Bionik Laboratories Corp. (BNKL)
                            6.3.11.1. Company overview
                            6.3.11.2. Financial performance
                            6.3.11.3. Product benchmarking
                            6.3.11.4. Strategic initiatives
                        6.3.12. BioXtreme Ltd.
                            6.3.12.1. Company overview
                            6.3.12.2. Financial performance
                            6.3.12.3. Product benchmarking
                            6.3.12.4. Strategic initiatives
                        6.3.13. Ekso Bionics
                            6.3.13.1. Company overview
                            6.3.13.2. Financial performance
                            6.3.13.3. Product benchmarking
                            6.3.13.4. Strategic initiatives
                        6.3.14. Saebo, Inc
                            6.3.14.1. Company overview
                            6.3.14.2. Financial performance
                            6.3.14.3. Product benchmarking
                            6.3.14.4. Strategic initiatives
                        6.3.15. Kinova inc.
                            6.3.15.1. Company overview
                            6.3.15.2. Financial performance
                            6.3.15.3. Product benchmarking
                            6.3.15.4. Strategic initiatives
                        6.3.16. Kinestica
                            6.3.16.1. Company overview
                            6.3.16.2. Financial performance
                            6.3.16.3. Product benchmarking
                            6.3.16.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. U.S. Neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
Table 4 U.S. U.S. Neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. Neurorehabilitation devices market: Market snapshot
Fig. 9 U.S. Neurorehabilitation devices market: Market segmentation
Fig. 10 U.S. Neurorehabilitation devices market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 U.S. Neurorehabilitation devices market driver impact
Fig. 14 U.S. Neurorehabilitation devices market restraint impact
Fig. 15 U.S. Neurorehabilitation devices market porter’s five forces analysis
Fig. 16 U.S. Neurorehabilitation devices market PESTEL analysis
Fig. 17 U.S. Neurorehabilitation devices market segment dashboard
Fig. 18 U.S. Neurorehabilitation devices market: Product movement Analysis
Fig. 19 Neurorobotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Brain-computer interface market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Wearable devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Non-invasive stimulators market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 U.S. Neurorehabilitation devices market: Therapy area movement Analysis
Fig. 25 Stroke market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Parkinson’s disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Multiple sclerosis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Cerebral palsy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)